2012
DOI: 10.3109/14767058.2012.735998
|View full text |Cite
|
Sign up to set email alerts
|

Incidence of β-thalassemia carrier on 1495 couples in preconceptional period

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
5
0

Year Published

2014
2014
2023
2023

Publication Types

Select...
5

Relationship

2
3

Authors

Journals

citations
Cited by 5 publications
(5 citation statements)
references
References 8 publications
0
5
0
Order By: Relevance
“…β-Thalassaemia is an inherited anaemia resulting from genome variants in β-globin chains. This disease is most prevalent in Africa, 1 Asia, 2 Mediterranean 3 and the Middle East. 4 Quantification of haemoglobin alpha 2 (HbA 2 ) percentage by capillary electrophoresis and routine haematology testing are the existing methods for screening thalassaemia and haemoglobinopathies.…”
Section: Introductionmentioning
confidence: 99%
“…β-Thalassaemia is an inherited anaemia resulting from genome variants in β-globin chains. This disease is most prevalent in Africa, 1 Asia, 2 Mediterranean 3 and the Middle East. 4 Quantification of haemoglobin alpha 2 (HbA 2 ) percentage by capillary electrophoresis and routine haematology testing are the existing methods for screening thalassaemia and haemoglobinopathies.…”
Section: Introductionmentioning
confidence: 99%
“…Of 37 studies regarding factors affecting RBC indices, 67.6% (n=25) identified silent or mild β-thalassemia carriers with normal or marginal MCV and/or MCH. Of 25 studies, 6 (24%) originated from Italy, 6 , 22-26 5 (20%) from India, 14 , 27-30 4 (16%) from China, 31-34 2 (8%) each from Thailand, 35 , 36 Iran 37 , 38 and Pakistan, 39 , 40 one (4%) each from Turkey, 41 Bahrain, 42 Malaysia, 43 and Spain. 44 Silent or mild β-thalassemia mutations reported from different countries are listed in Table 1 .…”
Section: Resultsmentioning
confidence: 99%
“…This paper aimed to highlight how the study based on biochemical data alone, in some cases, is not reliable to correctly highlight the related genetic defect. This could lead to an incorrect clinical assessment resulting in an inaccurate prognosis [1,2].…”
Section: Introductionmentioning
confidence: 99%